ProQR Therapeutics NV (NASDAQ:PRQR)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - PRQR

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - PRQR

  • Market Cap$209.600m
  • SymbolNASDAQ:PRQR
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINNL0010872495

Company Profile

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa. The company's main product candidates are QR-010, QR-110, and QR-313. Its product pipeline includes QRX-704, QRX-504, QRX-421, QRX-323 etc.ProQR Therapeutics NV is a biopharmaceutical company engaged in the discovery & development of RNA-based therapeutics for the treatment of severe genetic disorders.

Latest PRQR news

Currently there for this company. Visit our news hub for other news .